PIQ — Proteomics International Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- AU$19.82m
- AU$16.40m
- AU$3.37m
Annual cashflow statement for Proteomics International Laboratories, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.005 | 0.11 | 0.242 | 0.234 | 0.241 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.54 | -5.69 | -5.59 | -6.6 | -5.87 |
| Capital Expenditures | -0.129 | -1.22 | -0.403 | -0.03 | -2.01 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.053 | 0.015 | 0 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.129 | -1.17 | -0.388 | -0.03 | -2.01 |
| Financing Cash Flow Items | — | -0.063 | 0.063 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.176 | 10.8 | 6.59 | 11 | 0.345 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.49 | 3.92 | 0.613 | 4.4 | -7.54 |